{"id":"W2019150265","doi":"10.1053/j.gastro.2014.08.003","title":"Converging Goals of Treatment of Inflammatory Bowel Disease From Clinical Trials and Practice","year":2014,"lang":"en","type":"review","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":216,"is_retracted":false,"has_abstract":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Janssen Pharmaceuticals; Janssen Biotech; Janssen Research and Development; Genentech; Novo Nordisk; Optimer Pharmaceuticals; Luitpold Pharmaceuticals; Shire; Bristol-Myers Squibb; Orexigen Therapeutics; Amgen; Boehringer Ingelheim; G1 Therapeutics; Celgene; Pfizer; MedImmune; GlaxoSmithKline; AbbVie; Abbott Laboratories","keywords":"Medicine; Clinical trial; Inflammatory bowel disease; Clinical Practice; Disease; Ulcerative colitis; Endoscopy; Crohn's disease; Intensive care medicine; Physical therapy; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002044468,0.000461928,0.002604016,0.0000986767,0.0000261554,0.000008898907,0.0002557996,0.0004349473,0.00003113957],"category_scores_gemma":[0.002800303,0.0003813055,0.001043168,0.0000210302,0.000436125,0.000005880172,0.0001865055,0.0001252303,0.000009379732],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003173536,"about_ca_system_score_gemma":0.0003730648,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009155736,"about_ca_topic_score_gemma":0.00001337678,"domain_scores_codex":[0.990928,0.005695504,0.002272207,0.0006684838,0.0001228278,0.0003129912],"domain_scores_gemma":[0.995317,0.0008831191,0.002505739,0.000843324,0.0001315402,0.0003192125],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03992786,0.003054863,0.2516229,0.03518863,0.02042075,0.000993603,0.0001863032,0.00003316421,0.0005787991,0.0002518022,0.004719625,0.6430217],"study_design_scores_gemma":[0.003861499,0.002106444,0.01235566,0.001383947,0.006469145,0.00003931896,0.00002199425,0.00001411821,0.00001225974,0.00002271984,0.9734038,0.0003090994],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.06540029,0.9317249,0.000200514,0.00003385018,0.0005065319,0.001072591,0.001012463,0.00001092851,0.00003789409],"genre_scores_gemma":[0.003537171,0.9944259,0.0003130202,0.0001278246,0.0005944254,0.0001133549,0.0007981408,0.00005534583,0.00003484593],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9686842,"threshold_uncertainty_score":0.9998639,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06271457374047619,"score_gpt":0.402497071479209,"score_spread":0.3397824977387329,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}